Wangsu Science & Technology Co.,Ltd. (SHE:300017)
17.30
+1.30 (8.13%)
May 6, 2026, 3:12 PM CST
SHE:300017 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 4,501 | 4,620 | 4,891 | 4,671 | 5,056 | 4,552 |
Other Revenue | 40.77 | 40.77 | 40.84 | 34.55 | 27.77 | 22.65 |
| 4,541 | 4,661 | 4,932 | 4,705 | 5,084 | 4,575 | |
Revenue Growth (YoY) | -10.02% | -5.50% | 4.81% | -7.45% | 11.13% | -19.55% |
Cost of Revenue | 2,853 | 3,004 | 3,384 | 3,199 | 3,753 | 3,418 |
Gross Profit | 1,688 | 1,657 | 1,548 | 1,507 | 1,331 | 1,157 |
Selling, General & Admin | 786.82 | 754.95 | 707 | 690.28 | 658.58 | 696.75 |
Research & Development | 397.89 | 409.44 | 454 | 481.78 | 504.4 | 543.19 |
Other Operating Expenses | 21.45 | 18.19 | 13.85 | 14.06 | 13.57 | 13 |
Operating Expenses | 1,211 | 1,183 | 1,164 | 1,161 | 1,189 | 1,255 |
Operating Income | 477.15 | 473.43 | 383.48 | 345.93 | 141.78 | -98.29 |
Interest Expense | -13.66 | -14.42 | -7.29 | -7.63 | -16.45 | -14.13 |
Interest & Investment Income | 282.12 | 315.29 | 213.05 | 253.47 | 60.05 | 154.85 |
Currency Exchange Gain (Loss) | -81.79 | -81.79 | 42.46 | 26.9 | 34.25 | -9.27 |
Other Non Operating Income (Expenses) | -57.17 | -1.06 | -14.22 | -1.32 | -2.54 | -3.09 |
EBT Excluding Unusual Items | 606.65 | 691.45 | 617.48 | 617.35 | 217.08 | 30.06 |
Gain (Loss) on Sale of Investments | 133.21 | 127.02 | 38.31 | -4.16 | -18.53 | 102.76 |
Gain (Loss) on Sale of Assets | 4.95 | 5.65 | 24.35 | 3.14 | 7.86 | 7.6 |
Asset Writedown | -4.47 | -4.47 | -7.48 | -43.66 | -37.55 | -48.23 |
Other Unusual Items | 43.21 | 39.94 | 54.06 | 78.77 | 25.21 | 45.54 |
Pretax Income | 783.55 | 859.59 | 726.73 | 651.43 | 194.07 | 137.74 |
Income Tax Expense | 57.95 | 64.4 | 55.55 | 44.99 | 9.94 | -25.95 |
Earnings From Continuing Operations | 725.61 | 795.19 | 671.17 | 606.44 | 184.13 | 163.69 |
Minority Interest in Earnings | 2.83 | 4.34 | 3.35 | 6.66 | 6.46 | 1.55 |
Net Income | 728.43 | 799.53 | 674.52 | 613.1 | 190.59 | 165.24 |
Net Income to Common | 728.43 | 799.53 | 674.52 | 613.1 | 190.59 | 165.24 |
Net Income Growth | 0.08% | 18.53% | 10.02% | 221.68% | 15.34% | -24.89% |
Shares Outstanding (Basic) | 2,427 | 2,423 | 2,409 | 2,452 | 2,382 | 2,361 |
Shares Outstanding (Diluted) | 2,508 | 2,499 | 2,498 | 2,452 | 2,382 | 2,361 |
Shares Change (YoY) | 0.27% | 0.01% | 1.87% | 2.94% | 0.92% | -3.43% |
EPS (Basic) | 0.30 | 0.33 | 0.28 | 0.25 | 0.08 | 0.07 |
EPS (Diluted) | 0.29 | 0.32 | 0.27 | 0.25 | 0.08 | 0.07 |
EPS Growth | -0.19% | 18.52% | 8.00% | 212.50% | 14.29% | -22.22% |
Free Cash Flow | 720.76 | 821.29 | 731.31 | 705.04 | 743.01 | 580.69 |
Free Cash Flow Per Share | 0.29 | 0.33 | 0.29 | 0.29 | 0.31 | 0.25 |
Dividend Per Share | 0.250 | 0.250 | 0.250 | 0.250 | 0.050 | 0.030 |
Dividend Growth | - | - | - | 400.00% | 66.67% | 200.00% |
Gross Margin | 37.17% | 35.55% | 31.38% | 32.02% | 26.18% | 25.29% |
Operating Margin | 10.51% | 10.16% | 7.78% | 7.35% | 2.79% | -2.15% |
Profit Margin | 16.04% | 17.15% | 13.68% | 13.03% | 3.75% | 3.61% |
Free Cash Flow Margin | 15.87% | 17.62% | 14.83% | 14.98% | 14.61% | 12.69% |
EBITDA | 617.34 | 632.04 | 615.77 | 670.35 | 538.19 | 387.16 |
EBITDA Margin | 13.59% | 13.56% | 12.48% | 14.25% | 10.59% | 8.46% |
D&A For EBITDA | 140.19 | 158.61 | 232.29 | 324.42 | 396.41 | 485.45 |
EBIT | 477.15 | 473.43 | 383.48 | 345.93 | 141.78 | -98.29 |
EBIT Margin | 10.51% | 10.16% | 7.78% | 7.35% | 2.79% | -2.15% |
Effective Tax Rate | 7.40% | 7.49% | 7.64% | 6.91% | 5.12% | - |
Revenue as Reported | 4,541 | 4,661 | 4,932 | 4,705 | 5,084 | 4,575 |
Advertising Expenses | - | 10.1 | 10.09 | 10.91 | 8.17 | 9.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.